{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:23:13Z","timestamp":1777029793031,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia","award":["RG24-L06"],"award-info":[{"award-number":["RG24-L06"]}]},{"name":"Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia","award":["RG24-L06"],"award-info":[{"award-number":["RG24-L06"]}]},{"name":"Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia","award":["RG24-L06"],"award-info":[{"award-number":["RG24-L06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01568-8","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:42:30Z","timestamp":1754325750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of Novel Scaffolds Against GSK-3\u03b2 for Targeting Alzheimer\u2019s Disease Through Molecular Modeling Techniques"],"prefix":"10.1007","volume":"45","author":[{"given":"Shafiul","family":"Haque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin M.","family":"Mathkor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshika","family":"Suri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biochi.2024.05.002","volume":"225","author":"F Ahmad","year":"2024","unstructured":"Ahmad F, Gupta A, Marzook H et al (2024) Natural compound screening predicts novel GSK-3 isoform-specific inhibitors. Biochimie 225:68\u201380. https:\/\/doi.org\/10.1016\/j.biochi.2024.05.002","journal-title":"Biochimie"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ipha.2023.12.008","volume":"2","author":"A Ajala","year":"2024","unstructured":"Ajala A, Eltayb WA, Abatyough TM et al (2024a) In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease. Intell Pharm 2:554\u2013564. https:\/\/doi.org\/10.1016\/j.ipha.2023.12.008","journal-title":"Intell Pharm"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ipha.2023.12.004","volume":"2","author":"A Ajala","year":"2024","unstructured":"Ajala A, Uzairu A, Shallangwa GA et al (2024b) QSAR application of natural therapeutics inhibitors against Alzheimer\u2019s disease through in-silico virtual-screening, docking-simulation, molecular dynamics, and pharmacokinetic prediction analysis. Intell Pharm 2:505\u2013515. https:\/\/doi.org\/10.1016\/j.ipha.2023.12.004","journal-title":"Intell Pharm"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40203-025-00305-9","volume":"13","author":"A Ajala","year":"2025","unstructured":"Ajala A, Asipita OH, Michael AT et al (2025) Therapeutic exploration potential of adenosine receptor antagonists through pharmacophore ligand-based modelling and pharmacokinetics studies against Parkinson disease. Silico Pharmacol 13:17. https:\/\/doi.org\/10.1007\/s40203-025-00305-9","journal-title":"Silico Pharmacol"},{"key":"1568_CR5","unstructured":"Alzforum (2019) Therapeutics: Tideglusib"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer\u2019s Association Report","year":"2024","unstructured":"Alzheimer\u2019s Association Report (2024) 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 20:3708\u20133821. https:\/\/doi.org\/10.1002\/alz.13809","journal-title":"Alzheimer\u2019s Dement"},{"key":"1568_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1021\/ci100026x","volume":"50","author":"I-J Chen","year":"2010","unstructured":"Chen I-J, Foloppe N (2010) Drug-like bioactive structures and conformational coverage with the LigPrep\/ConfGen suite: comparison to programs MOE and catalyst. J Chem Inf Model 50:822\u2013839. https:\/\/doi.org\/10.1021\/ci100026x","journal-title":"J Chem Inf Model"},{"key":"1568_CR8","first-page":"1","volume":"1","author":"E Chow","year":"2008","unstructured":"Chow E, Rendleman CA, Bowers KJ et al (2008) Desmond performance on a cluster of multicore processors. SIMULATION 1:1\u201314","journal-title":"SIMULATION"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00894-017-3395-8","volume":"23","author":"P Czele\u0144","year":"2017","unstructured":"Czele\u0144 P (2017) Inhibition mechanism of CDK-2 and GSK-3\u03b2 by a sulfamoylphenyl derivative of indoline: a molecular dynamics study. J Mol Model 23:230. https:\/\/doi.org\/10.1007\/s00894-017-3395-8","journal-title":"J Mol Model"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00894-015-2627-z","volume":"21","author":"P Czele\u0144","year":"2015","unstructured":"Czele\u0144 P, Szefler B (2015) Molecular dynamics study of the inhibitory effects of ChEMBL474807 on the enzymes GSK-3\u03b2 and CDK-2. J Mol Model 21:74. https:\/\/doi.org\/10.1007\/s00894-015-2627-z","journal-title":"J Mol Model"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Rao SN (2006) PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug des 67:370\u2013372. https:\/\/doi.org\/10.1111\/j.1747-0285.2006.00384.x","journal-title":"Chem Biol Drug des"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13065-024-01248-6","volume":"18","author":"M El Fadili","year":"2024","unstructured":"El Fadili M, Er-Rajy M, Mujwar S et al (2024) In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations. BMC Chem 18:142. https:\/\/doi.org\/10.1186\/s13065-024-01248-6","journal-title":"BMC Chem"},{"key":"1568_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","volume":"101","author":"C Ferrari","year":"2021","unstructured":"Ferrari C, Sorbi S (2021) The complexity of Alzheimer\u2019s disease: an evolving puzzle. Physiol Rev 101:1047\u20131081. https:\/\/doi.org\/10.1152\/physrev.00015.2020","journal-title":"Physiol Rev"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LLG Ferreira","year":"2019","unstructured":"Ferreira LLG, Andricopulo AD (2019) ADMET modeling approaches in drug discovery. Drug Discov Today 24:1157\u20131165. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.015","journal-title":"Drug Discov Today"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5958\/0974-4150.2021.00017.1","volume":"14","author":"AK Galande","year":"2021","unstructured":"Galande AK, Rohane SH (2021) Insilico molecular docking analysis in maestro software. Asian J Res Chem 14:1\u20134. https:\/\/doi.org\/10.5958\/0974-4150.2021.00017.1","journal-title":"Asian J Res Chem"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"17233","DOI":"10.3390\/ijms242417233","volume":"24","author":"S Galati","year":"2023","unstructured":"Galati S, Di Stefano M, Bertini S et al (2023) Identification of new GSK3\u03b2 inhibitors through a consensus machine learning-based virtual screening. Int J Mol Sci 24:17233. https:\/\/doi.org\/10.3390\/ijms242417233","journal-title":"Int J Mol Sci"},{"key":"1568_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-981-32-9358-8_16","volume-title":"Tau Biology","author":"G Gallardo","year":"2019","unstructured":"Gallardo G, Holtzman DM (2019) Amyloid-\u03b2 and Tau at the Crossroads of Alzheimer\u2019s Disease. In: Takashima A, Wolozin B, Buee L (eds) Tau Biology. Springer, Singapore, pp 187\u2013203"},{"key":"1568_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105149","volume":"114","author":"H Gao","year":"2021","unstructured":"Gao H, Jiang Y, Zhan J, Sun Y (2021) Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer\u2019s disease agents. Bioorg Chem 114:105149. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105149","journal-title":"Bioorg Chem"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"1568_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pro.3923","volume":"30","author":"BJ Grant","year":"2021","unstructured":"Grant BJ, Skj\u00e6rven L, Yao X (2021) The Bio3D packages for structural bioinformatics. Protein Sci 30:20\u201330. https:\/\/doi.org\/10.1002\/pro.3923","journal-title":"Protein Sci"},{"key":"1568_CR21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s","journal-title":"J Med Chem"},{"key":"1568_CR22","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.3233\/JAD-2012-129025","volume":"33","author":"F Hernandez","year":"2012","unstructured":"Hernandez F, Lucas JJ, Avila J (2012) GSK3 and Tau: two convergence points in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 33:S141\u2013S144. https:\/\/doi.org\/10.3233\/JAD-2012-129025","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3892\/mmr.2024.13318","volume":"30","author":"R Hu","year":"2024","unstructured":"Hu R, Xiao Z, Qiao M et al (2024) Construction and validation of a bioinformatics-based screen for cuproptosis-related genes and risk model for Alzheimer\u2019s disease. Mol Med Rep 30:194. https:\/\/doi.org\/10.3892\/mmr.2024.13318","journal-title":"Mol Med Rep"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/qsar.200730051","volume":"27","author":"L Ioakimidis","year":"2008","unstructured":"Ioakimidis L, Thoukydidis L, Mirza A et al (2008) Benchmarking the reliability of QikProp. correlation between experimental and predicted values. QSAR Comb Sci 27:445\u2013456. https:\/\/doi.org\/10.1002\/qsar.200730051","journal-title":"QSAR Comb Sci"},{"key":"1568_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00702-021-02449-2","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022) Recent update on the heterogeneity of the Alzheimer\u2019s disease spectrum. J Neural Transm 129:1\u201324. https:\/\/doi.org\/10.1007\/s00702-021-02449-2","journal-title":"J Neural Transm"},{"key":"1568_CR26","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/jcc.21778","volume":"32","author":"A Laoui","year":"2011","unstructured":"Laoui A, Polyakov VR (2011) Web services as applications\u2019 integration tool: QikProp case study. J Comput Chem 32:1944\u20131951. https:\/\/doi.org\/10.1002\/jcc.21778","journal-title":"J Comput Chem"},{"key":"1568_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta - Mol Cell Res 1867:118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"1568_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/00207454.2022.2130297","volume":"134","author":"DS Mandlik","year":"2024","unstructured":"Mandlik DS, Mandlik SK (2024) Therapeutic implications of glycogen synthase kinase-3\u03b2 in Alzheimer\u2019s disease: a novel therapeutic target. Int J Neurosci 134:603\u2013619. https:\/\/doi.org\/10.1080\/00207454.2022.2130297","journal-title":"Int J Neurosci"},{"key":"1568_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12017-022-08731-0","volume":"25","author":"SL Mehta","year":"2023","unstructured":"Mehta SL, Kim T, Chelluboina B, Vemuganti R (2023) Tau and GSK-3\u03b2 are critical contributors to \u03b1-synuclein-mediated post-stroke brain damage. NeuroMolecular Med 25:94\u2013101. https:\/\/doi.org\/10.1007\/s12017-022-08731-0","journal-title":"NeuroMolecular Med"},{"key":"1568_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R (2023) Alzheimer\u2019s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522. https:\/\/doi.org\/10.1016\/j.bcp.2023.115522","journal-title":"Biochem Pharmacol"},{"key":"1568_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1347","volume":"8","author":"AV Onufriev","year":"2018","unstructured":"Onufriev AV, Izadi S (2018) Water models for biomolecular simulations. Wires Comput Mol Sci 8:e1347. https:\/\/doi.org\/10.1002\/wcms.1347","journal-title":"Wires Comput Mol Sci"},{"key":"1568_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins Struct Funct Bioinforma 55:383\u2013394. https:\/\/doi.org\/10.1002\/prot.20033","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"1568_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.9734\/BJPR\/2015\/18013","volume":"7","author":"A Pinhiero","year":"2015","unstructured":"Pinhiero A, Silva K, Silva A et al (2015) In silico identification of novel potential BACE-1 inhibitors for Alzheimer\u2019s disease treatment: molecular docking, pharmacophore Modeling and activity and synthetic accessibility predictions. Br J Pharm Res 7:217\u2013229. https:\/\/doi.org\/10.9734\/BJPR\/2015\/18013","journal-title":"Br J Pharm Res"},{"key":"1568_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/0471141755.ph0912s49","volume":"49","author":"MP Pollastri","year":"2010","unstructured":"Pollastri MP (2010) Overview on the rule of five. Curr Protoc Pharmacol 49:9\u201312. https:\/\/doi.org\/10.1002\/0471141755.ph0912s49","journal-title":"Curr Protoc Pharmacol"},{"key":"1568_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.drudis.2018.11.005","volume":"24","author":"JA Pradeepkiran","year":"2019","unstructured":"Pradeepkiran JA, Reddy AP, Reddy PH (2019) Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer\u2019s disease. Drug Discov Today 24:616\u2013623. https:\/\/doi.org\/10.1016\/j.drudis.2018.11.005","journal-title":"Drug Discov Today"},{"key":"1568_CR36","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.3390\/molecules25235773","volume":"25","author":"R Purgatorio","year":"2020","unstructured":"Purgatorio R, Gambacorta N, Catto M et al (2020) Pharmacophore modeling and 3D-QSAR study of indole and isatin derivatives as antiamyloidogenic agents targeting Alzheimer\u2019s disease. Molecules 25:5773. https:\/\/doi.org\/10.3390\/molecules25235773","journal-title":"Molecules"},{"key":"1568_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6807-11-6","volume":"11","author":"M Rostkowski","year":"2011","unstructured":"Rostkowski M, Olsson MH, S\u00f8ndergaard CR, Jensen JH (2011) Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Struct Biol 11:6. https:\/\/doi.org\/10.1186\/1472-6807-11-6","journal-title":"BMC Struct Biol"},{"key":"1568_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL et al (2007) Epik: a software program for pK a prediction and protonation state generation for drug-like molecules. J Comput Aided Mol des 21:681\u2013691. https:\/\/doi.org\/10.1007\/s10822-007-9133-z","journal-title":"J Comput Aided Mol des"},{"key":"1568_CR39","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","volume":"6","author":"D Shivakumar","year":"2010","unstructured":"Shivakumar D, Williams J, Wu Y et al (2010) Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J Chem Theory Comput 6:1509\u20131519. https:\/\/doi.org\/10.1021\/ct900587b","journal-title":"J Chem Theory Comput"},{"key":"1568_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.34172\/apb.2023.071","volume":"13","author":"SR Shri","year":"2023","unstructured":"Shri SR, Manandhar S, Nayak Y, Pai KSR (2023) Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer\u2019s disease. Adv Pharm Bull 13:688\u2013700. https:\/\/doi.org\/10.34172\/apb.2023.071","journal-title":"Adv Pharm Bull"},{"key":"1568_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s43141-021-00163-w","volume":"19","author":"R Shukla","year":"2021","unstructured":"Shukla R, Singh TR (2021) High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3\u03b2 for Alzheimer\u2019s disease using computational approaches. J Genet Eng Biotechnol 19:61. https:\/\/doi.org\/10.1186\/s43141-021-00163-w","journal-title":"J Genet Eng Biotechnol"},{"key":"1568_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1574-1400(06)02013-5","volume":"22","author":"SAM Stein","year":"2006","unstructured":"Stein SAM, Loccisano AE, Firestine SM, Evanseck JD (2006) Chapter principal components analysis: a review of its application on molecular dynamics data. Annu Rep Comput Chem 22:233\u2013261","journal-title":"Annu Rep Comput Chem"},{"key":"1568_CR43","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","volume":"16","author":"T Tuccinardi","year":"2021","unstructured":"Tuccinardi T (2021) What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery? Expert Opin Drug Discov 16:1233\u20131237. https:\/\/doi.org\/10.1080\/17460441.2021.1942836","journal-title":"Expert Opin Drug Discov"},{"key":"1568_CR44","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J et al (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119:9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"1568_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan S, Chan HCS, Hu Z (2017) Using PyMOL as a platform for computational drug design. Wires Comput Mol Sci 7:e1298. https:\/\/doi.org\/10.1002\/wcms.1298","journal-title":"Wires Comput Mol Sci"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01568-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01568-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01568-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:23:44Z","timestamp":1765535024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01568-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01568-8","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable, as no human or animal subjects were used in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"77"}}